Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of Pramlintide in Diabetes Mellitus
NCT00042471Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Jun 2002
- Primary completion
- Dec 2002
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of pramlintide in type 1 diabetes mellitus (T1D), type 2 diabetes mellitus (T2DM), sponsored by AstraZeneca. Started Jun 2002; status: completed.
02
Drugs
pramlintide
03
Conditions
type 1 diabetes mellitus (T1D)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00042471.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00042471.